RxDoctor Payments Data

Atul Malhotra, MD

Sleep Medicine · San Diego, CANPI 1982695169

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $651,812 of the $771,193 with a category attached, or 84.5%. It is spread thinly across 22 manufacturers, the largest accounting for just 23.9%. 2025 is the largest year on record at $232,117, 7.0 times the $33,288 reported in 2019. Among sleep medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$771,193in general payments, 2019–2025

Across 211 payments — averaging $3654.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$184K
  • Eli Lilly$173K
  • Resmed Corp$119K
  • Jazz Pharmaceuticals Inc.$76K
  • ZOLL Respicardia, Inc.$62K
  • Itamar Medical Inc$60K
  • plus $95K from 16 others
$697,881in research payments, 2019–2025

Across 21 payments — averaging $33,232 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche Products Limited$579K
  • Resmed Corp$82K
  • Livanova USA, Inc.$37K

What the payments were for

  • Consulting fees$651,81285%
  • Speaking & faculty fees$86,77911%
  • Travel & lodging$24,2483%
  • Food & beverage$8,2581%
  • Education$950%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$771,193 in reported general payments places this provider in the 95th percentile of 200 sleep medicine providers in California.

See all sleep medicine providers in California

Medicare billing

Part B allowed, 2024
$126,803
Medicare patients
361
Services billed
999

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trazodone Hcl23$78

Paid to pharmacies, not to this prescriber.

Other sleep medicine in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →